person · Reporting owner

Wooster Richard

Disclosed activity across 2 companies

Tapewire entity: 90087
SEC CIK: 0001774790

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
ImageneBio, Inc.IKNA · Entity 7139	Director	June 07, 2024	June 10, 2024
Translate Bio, Inc.TBIO · Entity 135439	Chief Scientific Officer	March 09, 2021	March 09, 2021

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

ImageneBio, Inc.

Report date June 07, 2024 · Filed June 10, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.75 · Expires 2034-06-06	Direct	17,520	Reported balance After 2024-06-07 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2024-06-07 · Grant · Acquired 17,520 · Balance 17,520 F1: This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.

Filing footnotes · ownership attribution and instrument terms

F1: This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director.

Translate Bio, Inc.

Report date March 09, 2021 · Filed March 09, 2021

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $23.82 · Expires 2031-03-09	Direct	70,000	Reported balance After 2021-03-09 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2021-03-09 · Grant · Acquired 70,000 · Balance 70,000 F1: This option will vest as to 25% of the shares on March 9, 2022, and in thirty-six equal monthly installments thereafter as to the remaining shares though March 9, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: This option will vest as to 25% of the shares on March 9, 2022, and in thirty-six equal monthly installments thereafter as to the remaining shares though March 9, 2025.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 07, 2024 Filed Jun 10, 2024 16:15 UTC	ImageneBio, Inc. IKNA · Entity 7139	GrantStock Option (Right to Buy) · Derivative	17,520	$0.00 Strike: $1.75	$0.00	Disclosure SEC source: 0000950170-24-071308 · ownership.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,520 Underlying: Common Stock · 17,520 shares Expires 2034-06-06 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) June 7, 2025 or (ii) the date of the next annual meeting; provided, however, that all vesting shall cease if the director resigns from the Board or otherwise ceases to serve as a director. Read SEC document
June 09, 2023 Filed Jun 13, 2023 16:30 UTC	ImageneBio, Inc. IKNA · Entity 7139	GrantStock Option (Right to Buy) · Derivative	17,520	$0.00 Strike: $6.51	$0.00	Disclosure SEC source: 0000899243-23-015444 · doc4.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,520 Underlying: Common Stock · 17,520 shares Expires 2033-06-09 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) June 9, 2024 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director. Read SEC document
June 09, 2022 Filed Jun 13, 2022 18:05 UTC	ImageneBio, Inc. IKNA · Entity 7139	GrantStock Option (Right to Buy) · Derivative	13,419	$0.00 Strike: $4.85	$0.00	Disclosure SEC source: 0000899243-22-022233 · doc4.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,419 Underlying: Common Stock · 13,419 shares Expires 2032-06-09 F1 · derivative.exercise_date: This option shall vest in full upon the earlier of (i) June 9, 2023 or (ii) the date of the next annual meeting, all vesting shall cease if the director resigns from the Board or otherwise ceases to service as a director. Read SEC document
January 21, 2022 Filed Jan 25, 2022 21:34 UTC	ImageneBio, Inc. IKNA · Entity 7139	GrantStock Option (Right to Buy) · Derivative	29,200	$0.00 Strike: $11.06	$0.00	Disclosure SEC source: 0000899243-22-003237 · doc4.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,200 Underlying: Common Stock · 29,200 shares Expires 2032-01-21 F1 · derivative.exercise_date: This option will vest in equal installments on the first, second, and third anniversaries of the grant date. Read SEC document
March 09, 2021 Filed Mar 9, 2021 20:26 UTC	Translate Bio, Inc. TBIO · Entity 135439	GrantStock Option (right to buy) · Derivative	70,000	$0.00 Strike: $23.82	$0.00	Disclosure SEC source: 0001209191-21-019303 · doc4.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 70,000 shares Expires 2031-03-09 F1 · derivative.exercise_date: This option will vest as to 25% of the shares on March 9, 2022, and in thirty-six equal monthly installments thereafter as to the remaining shares though March 9, 2025. Read SEC document
March 03, 2020 Filed Mar 5, 2020 19:56 UTC	Translate Bio, Inc. TBIO · Entity 135439	GrantStock Option (right to buy) · Derivative	150,000	$0.00 Strike: $7.66	$0.00	Disclosure SEC source: 0001209191-20-016805 · doc4.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2030-03-02 F1 · derivative.exercise_date: This option will vest as to 25% of the shares on March 3, 2021, and in thirty-six equal monthly installments thereafter as to the remaining shares through March 3, 2024. Read SEC document
April 24, 2019 Filed Apr 26, 2019 18:19 UTC	Translate Bio, Inc. TBIO · Entity 135439	GrantStock Option (right to buy) · Derivative	360,000	$0.00 Strike: $9.40	$0.00	Disclosure SEC source: 0001209191-19-026311 · doc4.xml · derivative · entry 1 Wooster Richard · CIK 0001774790 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 360,000 shares Expires 2029-04-23 F1 · derivative.exercise_date: This option will vest as to 25% of the shares on April 24, 2020, and in thirty-six equal monthly installments thereafter as to the remaining shares through April 24, 2023. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.